Table 2. Significant upregulated and downregulated metabolites between the SDP group and LDP group.
| Name | HMDB | Molecular weight | RT [min] | P value | Fold change |
|---|---|---|---|---|---|
| Upregulated | |||||
| Crustecdysone | HMDB0030180 | 480.30353 | 7.55 | 8.28E-04 | 1.64 |
| LysoPE(18:1(11Z)/0:0) | HMDB0011505 | 479.30012 | 7.56 | 4.17E-03 | 1.69 |
| Amidosulfonic acid | HMDB34830 | 96.98337 | 0.72 | 8.53E-03 | 1.09 |
| Palmitic acid | HMDB0000220 | 256.23991 | 8.46 | 1.72E-02 | 1.42 |
| Cytosine | HMDB0000630 | 111.0436 | 10.84 | 2.00E-02 | 2.05 |
| Varanic acid | HMDB0002195 | 436.31822 | 10.34 | 2.16E-02 | 2.24 |
| LysoPA(16:0/0:0) | HMDB0007853 | 410.2422 | 8.47 | 2.17E-02 | 1.46 |
| LysoPC(18:3(6Z,9Z,12Z)/0:0) | HMDB0010387 | 517.31315 | 8.48 | 2.30E-02 | 1.38 |
| LysoPC(16:1(9Z)/0:0) | HMDB0010383 | 493.31647 | 7.57 | 2.55E-02 | 1.74 |
| SM(d18:1/15:0) | HMDB0240608 | 688.54896 | 11.29 | 2.59E-02 | 2.04 |
| Cholinephosphate | HMDB0001565 | 183.0658 | 8.23 | 2.70E-02 | 2.17 |
| LysoPC(16:0/0:0) | HMDB0010382 | 495.33073 | 8.46 | 2.71E-02 | 1.26 |
| LysoPC(20:3(5Z,8Z,11Z)/0:0) | HMDB0010393 | 545.34695 | 8.45 | 3.22E-02 | 1.44 |
| L-Threose | HMDB0002649 | 120.0426 | 0.96 | 3.49E-02 | 1.31 |
| Nutriacholic acid | HMDB0000467 | 390.27631 | 9.60 | 3.74E-02 | 2.54 |
| LysoPC(15:0/0:0) | HMDB0010381 | 481.3162 | 7.81 | 4.01E-02 | 2.27 |
| LysoPE(0:0/20:1(11Z)) | HMDB0011482 | 507.33229 | 8.18 | 4.20E-02 | 2.14 |
| Downregulated | |||||
| N-Acetylglutamine | HMDB0006029 | 188.07956 | 1.02 | 4.43E-04 | 0.79 |
| Acetyl-L-carnitine | HMDB0240773 | 204.06059 | 0.86 | 5.91E-03 | 0.77 |
| L-isoglutamine | 144.08987 | 0.95 | 6.69E-05 | 0.75 | |
| Edetic Acid | HMDB0015109 | 292.08991 | 0.98 | 5.29E-06 | 0.74 |
| Valylserine | HMDB0029136 | 204.11091 | 0.97 | 1.50E-05 | 0.73 |
| L-2-Amino-4-methylenepentanedioic acid | HMDB0029433 | 159.05297 | 0.97 | 2.43E-05 | 0.72 |
| Propylhexedrine | HMDB0015659 | 155.0482 | 16.58 | 9.75E-03 | 0.71 |
| Threonylglycine | HMDB0029061 | 176.08003 | 1.04 | 2.40E-04 | 0.71 |
| trans-4-Hydroxy-L-proline | HMDB0000725 | 131.05801 | 0.96 | 3.40E-03 | 0.68 |
| Mannitol | HMDB0000765 | 182.07882 | 0.88 | 5.69E-03 | 0.66 |
| 2-hexenal | HMDB0031496 | 98.07298 | 4.61 | 4.25E-02 | 0.64 |
| Glutamylserine | HMDB0028828 | 234.08514 | 0.89 | 1.14E-03 | 0.64 |
| (4E)-2-Oxohexenoicacid | 128.04707 | 0.88 | 4.09E-05 | 0.63 | |
| L-Fucose | HMDB0000174 | 164.06828 | 0.87 | 7.39E-03 | 0.62 |
| 5,6-Dihydrouridine | HMDB00497 | 246.08488 | 0.96 | 7.38E-05 | 0.62 |
| 2-Furanmethanol | HMDB0013742 | 98.03649 | 0.90 | 9.39E-03 | 0.61 |
| Alanylthreonine | HMDB0028697 | 190.09515 | 0.89 | 2.03E-04 | 0.60 |
| dIMP | HMDB0006555 | 332.04384 | 0.91 | 3.88E-03 | 0.59 |
| L-2,4-Diaminobutyric acid | HMDB06284 | 216.0743 | 0.92 | 5.10E-05 | 0.59 |
| Ubiquinone-9 | HMDB06707 | 794.62437 | 16.96 | 1.68E-03 | 0.48 |
| PE-NMe2(14:0/20:1(11Z)) | HMDB0113859 | 745.56251 | 10.25 | 7.81E-03 | 0.45 |
| PC(15:0/18:1(11Z)) | HMDB0007938 | 745.56117 | 7.67 | 1.24E-02 | 0.44 |
| 9-Oxooctadecanoic acid | HMDB0030979 | 298.24833 | 8.83 | 3.40E-02 | 0.39 |
| SM(d18:1/18:0) | HMDB0001348 | 730.59947 | 11.84 | 1.89E-02 | 0.39 |
| PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z)) | HMDB0008729 | 831.57775 | 16.80 | 8.43E-03 | 0.34 |
| PE(MonoMe(11, 3)/MonoMe(13, 5)) | HMDB0061523 | 851.56518 | 11.47 | 1.93E-03 | 0.33 |
| PE-NMe(20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z)) | HMDB0113474 | 827.54521 | 12.25 | 1.77E-02 | 0.33 |
| PS(18:1(11Z)/15:0) | HMDB0112387 | 747.5251 | 10.80 | 4.77E-02 | 0.31 |
| PE(22:4(7Z,10Z,13Z,16Z)/P-18:0) | HMDB0009610 | 779.56477 | 11.61 | 1.88E-03 | 0.29 |
| LacCer(d18:1/12:0) | HMDB0004866 | 805.55141 | 8.14 | 4.93E-03 | 0.28 |
| PA(20:3(5Z,8Z,11Z)/24:0) | HMDB0115142 | 810.59672 | 16.97 | 2.80E-04 | 0.26 |
| PE-NMe(22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z)) | HMDB0113668 | 855.59254 | 9.14 | 9.01E-04 | 0.21 |
| PG(i-13:0/a-25:0) | HMDB0116677 | 806.59981 | 11.27 | 2.20E-03 | 0.19 |
| PS(24:1(15Z)/15:0) | HMDB0112912 | 831.5959 | 7.39 | 5.50E-04 | 0.18 |
| PS(15:0/24:1(15Z)) | HMDB0112341 | 831.60493 | 6.56 | 3.28E-03 | 0.18 |
| PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:6 (4Z,7Z,10Z,13Z,16Z,19Z)) |
HMDB0008518 | 851.5348 | 10.78 | 1.19E-02 | 0.17 |
| PS(22:0/15:0) | HMDB0112709 | 805.5797 | 11.57 | 2.21E-05 | 0.12 |
| PA(22:0/22:5(4Z,7Z,10Z,13Z,16Z)) | HMDB0115170 | 806.59132 | 6.56 | 1.95E-03 | 0.11 |
| PE-NMe(18:0/22:5(4Z,7Z,10Z,13Z,16Z)) | HMDB0113105 | 807.58778 | 8.32 | 6.80E-04 | 0.08 |
| PS(15:0/22:0) | HMDB0112334 | 805.59119 | 6.82 | 1.77E-02 | 0.04 |
| PE(22:1(13Z)/15:0) | HMDB0009516 | 759.57555 | 11.70 | 2.47E-09 | 0.03 |
| PC(18:1(9Z)/18:1(9Z)) | HMDB0000593 | 785.59374 | 17.00 | 4.15E-07 | 0.03 |
HMDB, the human metabolome database; RT, retention time; SDP, short duration of phototherapy; LDP, long duration of phototherapy; PE, phosphatidylethanolamine; PC, phosphatidylcholine; PS, phosphatidylserine; PA, phosphatidic acid; SM, sphingomyelin; dIMP, deoxyinosine-5'-monophosphate.